Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.

Bihrer V, Waidmann O, Friedrich-Rust M, Forestier N, Susser S, Haupenthal J, Welker M, Shi Y, Peveling-Oberhag J, Polta A, von Wagner M, Radeke HH, Sarrazin C, Trojan J, Zeuzem S, Kronenberger B, Piiper A.

PLoS One. 2011;6(10):e26971. doi: 10.1371/journal.pone.0026971. Epub 2011 Oct 31.

2.

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.

Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A.

Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.

PMID:
21606975
4.

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.

Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, Waidmann O.

Eur J Cancer. 2013 Nov;49(16):3442-9. doi: 10.1016/j.ejca.2013.06.002. Epub 2013 Jun 26.

PMID:
23810247
5.

Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.

Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW.

Liver Int. 2011 Oct;31(9):1352-8. doi: 10.1111/j.1478-3231.2011.02570.x. Epub 2011 Jun 23.

PMID:
21745311
6.

Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.

Moussa YI, Plevris JN, Hayes PC.

Eur J Gastroenterol Hepatol. 2000 Feb;12(2):159-63.

PMID:
10741929
7.

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.

van der Meer AJ, Farid WR, Sonneveld MJ, de Ruiter PE, Boonstra A, van Vuuren AJ, Verheij J, Hansen BE, de Knegt RJ, van der Laan LJ, Janssen HL.

J Viral Hepat. 2013 Mar;20(3):158-66. doi: 10.1111/jvh.12001. Epub 2012 Aug 27.

PMID:
23383654
8.

Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.

El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.

Mol Diagn Ther. 2015 Aug;19(4):213-20. doi: 10.1007/s40291-015-0148-1.

PMID:
26133725
9.

Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.

Sumie S, Kawaguchi T, Kuromatsu R, Takata A, Nakano M, Satani M, Yamada S, Niizeki T, Torimura T, Sata M.

PLoS One. 2011;6(11):e26840. doi: 10.1371/journal.pone.0026840. Epub 2011 Nov 14.

10.

Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.

Li L, Guo Z, Wang J, Mao Y, Gao Q.

Dig Dis Sci. 2012 Nov;57(11):2910-6. doi: 10.1007/s10620-012-2317-y. Epub 2012 Aug 5.

PMID:
22865399
11.

Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies.

Lendvai G, Jármay K, Karácsony G, Halász T, Kovalszky I, Baghy K, Wittmann T, Schaff Z, Kiss A.

World J Gastroenterol. 2014 Nov 7;20(41):15343-50. doi: 10.3748/wjg.v20.i41.15343.

12.

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.

Kobayashi M, Suzuki F, Akuta N, Suzuki Y, Sezaki H, Yatsuji H, Kawamura Y, Hosaka T, Kobayashi M, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Miyakawa Y, Kumada H.

Scand J Gastroenterol. 2009;44(8):975-83. doi: 10.1080/00365520802588125.

PMID:
19521923
13.

Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.

Kobeisy MA, Morsy KH, Galal M, Sayed SK, Ashmawy MM, Mohammad FM.

Arab J Gastroenterol. 2012 Jun;13(2):49-53. doi: 10.1016/j.ajg.2012.06.004. Epub 2012 Jul 11.

PMID:
22980591
14.

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.

Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D.

Mol Carcinog. 2011 Feb;50(2):136-42. doi: 10.1002/mc.20712. Epub 2010 Dec 10.

PMID:
21229610
15.

Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.

Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.

Liver Int. 2006 Nov;26(9):1095-9.

PMID:
17032410
16.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
17.

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.

Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K.

J Med Virol. 2015 Oct;87(10):1722-6. doi: 10.1002/jmv.24230. Epub 2015 May 11.

PMID:
25963774
19.

Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.

Kubo S, Yamamoto T, Ikebe T, Shuto T, Hirohashi K, Tanaka H, Tsukamoto T, Wakasa K, Kinoshita H.

Jpn J Cancer Res. 1999 Oct;90(10):1076-80.

PMID:
10595735
20.

High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.

Aroucha DC, do Carmo RF, Moura P, Silva JL, Vasconcelos LR, Cavalcanti MS, Muniz MT, Aroucha ML, Siqueira ER, Cahú GG, Pereira LM, Coêlho MR.

Cytokine. 2013 Jun;62(3):421-5. doi: 10.1016/j.cyto.2013.03.024. Epub 2013 Apr 16.

PMID:
23602201

Supplemental Content

Support Center